KISS1 and Stroke: Whilst we found that kisspeptin immunoreactivity was increased in both stroke cohorts, ICH CAA showed a non-significant trend of increased kisspeptin immunoreactivity in microvasculature cells as well as the haemorrhage site when compared to the ICH group.